ANKARA — Physicians have launched the world’s first mRNA lung cancer vaccine trial across seven countries, including Türkiye, in a groundbreaking effort that could revolutionize cancer treatment, according to press reports on Friday.
The vaccine, known as BNT116 and developed by BioNTech, is designed to target non-small cell lung cancer (NSCLC), the most common type of lung cancer.
UNITED NATIONS — The head of the United Nations warned gathered leaders Tuesday (Wednesday in Manila) that impunity, inequality and uncertainty are driving modern civilization toward “a powder keg that risks engulfing the world” — […]
TOKYO — The world’s first wooden satellite has blasted off on a SpaceX rocket, its Japanese developers said Tuesday, part of a resupply mission to the International Space Station. Scientists at Kyoto University expect the […]
KRISHNAH Marie Gravidez of Baguio City is Miss World Philippines 2024 and was crowned on the coronation night at the Mall of Asia Arena on Friday. First Princess was Jasmin Omay of Tarlac, and Second […]
Copyright ©2024 New Babylon Group of Companies OPC
Be the first to comment